Arbutus Biopharma earnings matched, revenue topped estimates — See source for full details.
$ABUS
Price history, market instrument context, member research, and related headlines in one place.
ABUS key statistics
NasdaqGSUSD
52-week range
$3.5041%$5.45
Latest session $4.22–$4.30Arbutus Biopharma Corporation (ABUS) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $4.29, up $0.10 (2.39%) from the previous close of $4.19. It has traded between $4.22 and $4.30 in the latest session. Over the past year it has ranged from $3.50 to $5.45, leaving it around the middle of its 52-week range (41%). Reported volume for the session was 2.3M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Arbutus Biopharma GAAP EPS of -$0.03 misses by $0.01, revenue of $1.01M beats by $0.33M — See source for full details.
Loading $ABUS research…